ClinicalTrials.gg
RecruitingNCT05277714CaDObUpdated Nov 19, 2026

Neurofeedback Based on Near-infrared Spectroscopy as a Therapy for Food Addiction in Obese Subjects.

An interventional study of Sham and NF in Obesity and Craving, sponsored by Rennes University Hospital. Recruiting at 1 site in France. Open to female participants aged 18 Years to 55 Years. Per ClinicalTrials.gov, last updated 2026-11-19.

Sponsored by Rennes University Hospital · Not applicable, Interventional, and Other

How we know

From the registry’s dates

  • Started May 2022; still recruiting 4 years 5 months later.
Updated Nov 19, 2026Primary completion movedStudy completion movedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
18 Years to 55 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 476 studies in Obesity with a site in France — 112 open to participants now, 128 under way, 25 of them phase 3. Obesity · France.

Planned enrollment
226th of 355
50 · median 80
Started
2022
with 26 others
No phase
259 of 476
64 open now
Primary completion
2027-05
later than 49 of 127 live
Registered
348th of 476
by date

Among the 476 studies in Obesity with a site in France, this one is the 226th largest by planned enrollment of the 355 interventional ones that give a count, is one of 27 that started in 2022, is one of 259 with no phase, reaches primary completion later than 49 of the 127 other live ones, and was the 348th registered.

Obesity

11,564 studies on the registry are indexed under Obesity; 2,063 are open to participants now.

Browse Obesity studies →

Open to participants now

112 of the 476 studies in Obesity with a site in France are open now. Recruiting first, the newest first:

107 more — sign in →

All 112 open studies →

A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →

Who these studies take

Of the 1,352 Obesity studies recruiting now, 382 (28%) set no upper age limit and 867 (64%) stop at 75 or younger; 169 take children under 18; 491 take healthy volunteers.

This study: 18 Years to 55 Years · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 476 studies in Obesity with a site in France, or all of them as a file.
02

Study summary

The hypothesis is that the increase in dlPFC brain activity via near-infrared spectroscopy-based Neurofeedback (fNIRS-based NF) training based on near-infrared spectroscopy would allow an improvement of the eating behavior, thus promoting a long-term weight loss in obese subjects.

Patients will be trained during a month with 8 NF sessions and results based on clinical data and different questionnaires results will be compared between inclusion and 3 months later

Read the detailed description

Obesity is a disease of increasing prevalence due in part to the greater availability of fatty, sugary and/or salty foods which, when consumed chronically and in excess, can lead to food addiction.

According to the neurocognitive model of addiction, the development and maintenance of addiction is associated with deficits in cognitive control, as well as a decrease prefrontal cortex (dlPFC). Self-control in food choice situations also depends on prefrontal network with the dlPFC as a hub, strongly connected with striatal and cingulate structures.

Neurofeedback (NF) is a technique that relies on the patient's positive or negative self-regulation of brain activity. It has been shown to be effective in several pathologies, in particular attention deficit/hyperactivity disorder in young people and more recently in depression and emotion regulation.

In this study, NF will be based on near-infrared spectroscopy (fNIRS), because its use is easy mobile and inexpensive. The hypothesis is that the increase in dlPFC brain activity via fNIR-based NF training based on fNIRS would allow an improvement of the eating behavior, thus promoting a long-term weight loss in obese subjects.

03

Conditions studied

  • Obesity
  • Craving

Browse trials for

04

Who can participate

Ages eligible
18 Years to 55 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Eligible for obesity surgery according to the 2009 French High Authority on Health (HAS) criteria ( ≥40 or BMI ≥35 with comorbidities)
  • Right-handed
  • Presenting a food addiction determined by the YFAS 2.0 questionnaire ;
  • Affiliated to a social security system;
  • Having given free and in writing.

Exclusion criteria

Exclusion Criteria:

  • Psychotic psychiatric disorders (schizophrenic disorders and bipolar disorders);
  • Psychotropic drugs, except antidepressants stabilized for at least 3 weeks and benzodiazepines
  • Addiction to alcohol or other psychoactive substances (except tobacco);
  • History of bariatric surgery;
  • Current treatment in the nutrition unit;
  • Insufficient command of French;
  • Pregnant or breast-feeding woman;
  • Persons of legal age under legal protection (safeguard of justice, curatorship, guardianship), persons deprived of liberty.
  • to fMRI
  • Inability to perform the fNIRS procedure due to blockage or attenuation of the light at the capillary level
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Single group
Masking
Single (Participant)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    NF

    Other: NF

  • Sham comparator
    Sham

    Other: Sham

Interventions

  • OtherSham

    The sham protocol will last 15 minutes per session, and during each session, the participants will receive the same instruction but will be shown a random signal, the goal being that the control strategy that the participant tries to implement is not correlated with the visual feedback provided by the gauge.

  • OtherNF

    The neurofeedback protocol will be the same during the 8 sessions constituting the protocol and taking place over a period of 4 weeks (2 neurofeedback sessions per week, the first and the last one in an MRI context). It will last 15 minutes per session, and during each session, the patient will have to increase the brain activity of her dlPFC using a visual gauge representing the "activity level" of her own dlPFC. No specific instructions will be given to the volunteer so that he/she can develop his/her own internal strategy to increase this "activity level".

06

What researchers measure

Primary outcomes

  1. Number of patients who have a difference in resting state IRM after NF session

    Difference in resting state IRM at inclusion and at 1 month after the 8th NF session between sham and experimental. Resting state IRM will allow to determine the correlation coefficient of the IRM BOLD signal fluctuations between the dlPFC and the striatum. The evolution of cognitive control by NeuroFeedback (NF) will thus be determined by a variation of this correlation coefficient and thus of the cortico-striatal connectivity at inclusion and after the 8th NF session.

    Time frame: 1 month

Secondary outcomes

  1. Number of patients who have a difference in resting state IRM after NF training in the cognitive food anticipation task condition

    Variation in hemodynamic BOLD response in the cognitive food anticipation task condition between V1 and V8 between groups (NF vs sham). Difference in resting state IRM at inclusion and at 1 month after the 8th NF session between sham and experimental. Resting state IRM will allow to determine the correlation coefficient of the IRM BOLD signal fluctuations between the dlPFC and the striatum. The evolution of cognitive control by NeuroFeedback (NF) will thus be determined by a variation of this correlation coefficient and thus of the cortico-striatal connectivity at inclusion and after the 8th NF session.

    Time frame: 1 month

  2. Difference in blood pressure status 3 months after NF training

    Evolution of health status using blood pressure (mmHg) between groups (NF vs sham) before and after participation (between V0 and V9).

    Time frame: 4 months

  3. Difference in blood pressure status 3 months after NF training

    Evolution of health status using clinical exam criteria between groups (NF vs sham) before and after participation (between V0 and V9).

    Time frame: 4 months

  4. Difference in biological check up 3 months after NF training

    Evolution of health status using biological check up between groups (NF vs sham) before and after participation (between V0 and V9).

    Time frame: 4 months

  5. Change of degree of correlation between EGG results and resting state IRM after NF training

    Variation in the degree of correlation between electrogastrogramm plots and resting state MRI between V1 and V8 and between groups (NF vs sham).

    Time frame: 1 month

  6. Difference in mental Heath status after NF training between groups

    Difference in anxiety and depression questionnaire (Hospital Anxiety and Depression Scale, questionnaire with 2 subscores, one for anxiety and one for depression. 0 = no anxiety/depression, 11 and more : anxiety/depression) after NF training between groups

    Time frame: 1 month

  7. Difference in mental Heath status training between groups after 3 months

    Difference in anxiety and depression questionnaire (Hospital Anxiety and Depression Scale, questionnaire with 2 subscores, one for anxiety and one for depression. 0 = no anxiety/depression, 11 and more : anxiety/depression) 3 months after NF training between groups

    Time frame: 4 months

  8. Difference in Food frequency questionnaire scores between groups after NF training

    Variation in FF questionnaire scores as a function of NF effect from inclusion to end of intervention. Food frequency questionnaire (FFQ) is a dietary assessment tool delivered as a questionnaire to estimate frequency and, in some cases, portion size information about food and beverage consumption over a specified period of time

    Time frame: 1 month

  9. Difference in Food Cravings Questionnaire-Trait-reduced scores between groups after NF training

    Variation in Food Cravings Questionnaire-Trait-reduced scores as a function of NF effect from inclusion to end of intervention. Food Cravings Questionnaire (FCQ), which consists of a trait (FCQ-T; 39 items) and state (FCQ-S; 15 items) version. FCQ-T-r is a self-administrated questionnaire consisted of 15-items scored using a Likert-type scale (1 = never, 2 = rarely, 3 = sometimes, 4 = usually, 6 = always), for possible total scores ranging from 15 to 90.

    Time frame: 1 month

  10. Difference in Food Cravings Questionnaire-Trait-reduced scores between groups 3 months after NF training

    Variation in Food Cravings Questionnaire-Trait-reduced scores as a function of NF effect from inclusion to 3 months after the end of intervention. Food Cravings Questionnaire (FCQ), which consists of a trait (FCQ-T; 39 items) and state (FCQ-S; 15 items) version. FCQ-T-r is a self-administrated questionnaire consisted of 15-items scored using a Likert-type scale (1 = never, 2 = rarely, 3 = sometimes, 4 = usually, 6 = always), for possible total scores ranging from 15 to 90.

    Time frame: 4 months

  11. Difference in Food frequency questionnaire scores between groups 3 months after NF training

    Variation in Food Frequency questionnaire scores as a function of NF effect from inclusion to end of intervention. Food frequency questionnaire (FFQ) is a dietary assessment tool delivered as a questionnaire to estimate frequency and, in some cases, portion size information about food and beverage consumption over a specified period of time

    Time frame: 4 months

  12. Difference in Three Factor Eating Questionnaire-R18 scores between groups 3 months after NF training

    Variation in Three Factor Eating Questionnaire-R18 questionnaire scores as a function of NF effect from inclusion to 3months after the end of intervention. The Three Factor Eating Questionnaire-R18 (TFEQ-R18) consists of 18 items on a 4-point response scale (definitely true/mostly true/mostly false/definitely false). Responses to each of the 18 items are given a score between 1 and 4 and item scores are summated into scale scores for cognitive restraint, uncontrolled eating, and emotional eating. Higher scores in the respective scales are indicative of greater cognitive restraint, uncontrolled, or emotional eating.

    Time frame: 4 months

  13. Difference in Three Factor Eating Questionnaire-R18 scores between groups after NF training

    Variation in Three Factor Eating Questionnaire-R18 questionnaire scores as a function of NF effect from inclusion to the end of intervention. The Three Factor Eating Questionnaire-R18 (TFEQ-R18) consists of 18 items on a 4-point response scale (definitely true/mostly true/mostly false/definitely false). Responses to each of the 18 items are given a score between 1 and 4 and item scores are summated into scale scores for cognitive restraint, uncontrolled eating, and emotional eating. Higher scores in the respective scales are indicative of greater cognitive restraint, uncontrolled, or emotional eating.

    Time frame: 1 month

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Renaud I, Coquery N, Guittiere MO, Godet A, Bannier E, Serrand Y, Moirand R, Thibault R, Val-Laillet D. Neurofeedback intervention based on functional near-infrared spectroscopy compared with sham control to improve inhibitory cognitive control in patients with severe obesity and food addiction: The protocol of a monocentric prospective randomized parallel-group single-blind interventional study. Clin Nutr ESPEN. 2026 Jul 11:103589. doi: 10.1016/j.clnesp.2026.103589. Online ahead of print. PubMed 42435898 ↗
09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started May 2022 (actual). Primary completion is estimated for May 2027, 60 months after the start.

Of 3,697 non-industry interventional studies with no phase under Obesity, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 43. This study's planned 60 months is above that.

Counting every sponsor, half of 3,861 studies reached it within 22 months; a quarter within 9 and three quarters within 42.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 19, 2026: primary completion May 2026 → May 2027 and completion Dec 2026 → Dec 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Mar 2, 2022
First posted
Mar 14, 2022
StartActual
May 25, 2022
Primary completionEst.
May 2027was May 2026
CompletionEst.
Dec 2027was Dec 2026
Last update
Nov 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
May 2026→May 2027
Nov 19, 2026
Study completion
Dec 2026→Dec 2027
Nov 19, 2026
Show all 1 update
  1. Nov 19, 2026
    Primary completion May 2026→May 2027
    Study completion Dec 2026→Dec 2027
    + 2 other changes: verification date and oversight details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT05277714
Responsible party
Sponsor
First posted
Mar 14, 2022
Start date
May 25, 2022
Primary completion
May 2027 (estimated)
Completion
Dec 2027 (estimated)
Last update
Nov 19, 2026

Study contacts

Marie-Laure GERVAIS
Contact
marie-laure.gervais@chu-rennes.fr
0618454735

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion